Version Changes
Revised. Amendments from Version 1
We thank the reviewers for the insightful comments. Based on the comments, we have made changes to and updated our article. In the abstract, the conclusion has been refined to make it more specific. To explain the difference in fasting glucose between the urban and rural settings, we have included pancreatic beta cell function as an outcome and reported the results. Occupation, as a possible proxy for activity levels, was added to the adjusted models and the new results from the analyses are presented in Tables 2 and 3. To further explore the role helminths in any observed differences in metabolic outcomes, the impact of S. mansoni infection intensity was analysed and the results are shown in Table 5. In the discussion, we made changes to highlight the relatively young study population and incorporated our previous trial findings. Furthermore, we included the possibility of non-compliance to overnight fasting and emphasised the role of diet and socioeconomic status in partially explaining the differences observed in the two settings.
Abstract
Background: The burden of cardiometabolic diseases, including cardiovascular diseases and diabetes, is increasing in sub-Saharan Africa and this has been linked to urbanisation. Helminths, through their immunomodulatory properties, may protect against these disorders. We hypothesised that the rural environment protects against cardiometabolic diseases and that helminths may influence rural-urban disparity of cardiometabolic disease risk.
Methods: We compared metabolic parameters of individuals aged ≥10 years living in rural, high-helminth-transmission and urban, lower-helminth-transmission settings in Uganda. Cross-sectional surveys were conducted in rural Lake Victoria island fishing communities and in urban sub-wards in Entebbe municipality. Helminth infection and outcomes, including insulin resistance (computed using the homeostatic model assessment of insulin resistance [HOMA-IR]), fasting blood glucose, fasting blood lipids, blood pressure, body mass index (BMI), waist and hip circumference, were assessed.
Results: We analysed 1,898 rural and 930 urban participants. Adjusting for BMI, exercise, smoking, alcohol intake, age and sex, urban residents had lower mean fasting glucose (adjusted mean difference [95%CI] 0.18 [-0.32, -0.05] p=0.01) and HOMA-IR (-0.26 [-0.40, -0.11] p=0.001) but higher blood pressure (systolic, 5.45 [3.75, 7.15] p<0.001; diastolic, 1.93 [0.57, 3.29] p=0.006). Current helminth infection did not explain the observed differences.
Conclusions: In the Ugandan context, living in rural fishing communities may protect against hypertension but worsen glucose metabolism.
Keywords: Rural, Urban, Metabolic, Hypertension, Diabetes, Insulin resistance, Helminths, Africa
Introduction
Globally, non-communicable diseases (NCDs) are the leading cause of mortality and disability. In 2016, they contributed to 72.3% of deaths 1, and cardiometabolic disorders were the top contributors to disability adjusted life years 2. The World Health Organisation (WHO) estimates that 78% of NCD related deaths occur in low and middle income countries and that the NCD burden is rapidly increasing in these countries 3. Sub-Saharan Africa, a region undergoing rapid economic growth, is experiencing this epidemiological transition, with the double burden of NCDs and communicable diseases.
The increased NCD burden has been linked to urbanisation and, currently, more than half of the world’s population lives in urban areas 4. Urban living is associated with traditional risk factors for cardiometabolic disease such as diets rich in energy-dense foods and reduced physical activity. This may suggest that the rural environment is protective against cardiometabolic diseases and various data sources confirm this 5– 7. However, there are reports of an increasing or already high burden of NCDs such as hypertension and diabetes in rural areas 8– 10 and no difference in burden between urban and rural settings 11. An increase in body mass index in rural areas has been identified as the main driver of the global epidemic of obesity 12.
The hygiene hypothesis proposes that the increase in chronic inflammatory disorders in high-income countries is linked to cleaner environments and less exposure to infectious agents 13. Exposure to infectious agents such as helminths modulates the immune system and may provide protection against these disorders. The urban environment is associated with less exposure to helminths compared to the rural environment. Recently, chronic inflammation has been linked to the aetiology of cardiometabolic disorders such as type 2 diabetes 14 and atherosclerosis 15, and has been proposed to have a role in essential hypertension 16. It remains unclear whether reduced exposure to helminth infections has contributed to the increase, and rural-urban differences, in cardiometabolic disease. There is evidence from animal studies, and the few published human studies, that through their effects on inflammation and metabolism, helminth infections are associated with favourable metabolic outcomes 17– 19.
We therefore tested the hypothesis that the rural environment is protective against metabolic risk factors and diseases and that helminths play a role in this. We investigated differences in metabolic parameters between a rural, high helminth transmission setting and an urban, lower helminth transmission setting in Uganda. We also investigated whether helminths might explain any differences observed between the two settings.
Methods
Study design and setting
We conducted parallel cross-sectional surveys, one in a rural and one in an urban setting ( Figure 1). The rural survey was the metabolic outcomes survey of the Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA). LaVIISWA was a cluster-randomised trial investigating the effects of intensive versus standard anthelminthic intervention on health outcomes in 26 rural Lake Victoria island communities of Koome sub-county, Mukono district, Uganda (population, 18,778) 20, 21. The metabolic outcomes survey was conducted between April and November 2017 after four years of the anthelminthic intervention 22. The survey in the urban setting was deliberately formulated to collect data in parallel with the LaVIISWA outcome surveys to enable rural-urban comparison of allergy-related 23, 24 and metabolic outcomes. It was conducted in Entebbe municipality, Wakiso district, Uganda from September 2016 to September 2017. Entebbe municipality is classified by the Uganda Bureau of Statistics as an urban area 25, and is located on the northern shores of Lake Victoria, with a population of 69,958 residing in 24 sub-wards (the smallest administrative units) 25.
Figure 1. Location of the study areas.

Participants
Household surveys were conducted in both settings. Households with members available at the time of conducting the surveys were eligible for inclusion. In the rural setting, the study team, in collaboration with the local leaders, maintained an updated register of all the households in the 26 study villages. This was used as a sampling frame to randomly select 70 households in each of the 26 study villages using Stata software (College Station, Texas, USA). In the urban setting, a different sampling technique was used because resources and time could not permit a complete household listing before starting the survey. With the help of locally available maps, we mapped each sub-ward onto satellite imagery of the area excluding areas that were uninhabited. The mapped sub-wards were then divided into segments of equal geographical size based on lines of latitude and longitude (degrees, minutes, seconds position format) and each segment was numbered. Using random number generation, segments were randomly selected from each sub-ward. The number of segments selected was proportional to the population size of the sub-ward. The midpoint of each selected segment was identified by its coordinates using a using a geographic information system (GIS) device (eTrex ®, Garmin™ Ltd, Kansas, United States). This was used as the starting point for sampling households and the nearest house was selected for inclusion. Houses were then sequentially selected, the next house to be sampled being the nearest to the previous house. In total, 120 geographical segments were targeted in the 24 sub-wards and in each segment, four households were targeted. If a household was empty or refused, the next one was approached until the number per segment was completed.
In both surveys, a household was defined as a habitable roofed structure whose primary function was residence or, if used for dual purposes, had at least one active resident using the structure as their primary residence. In selected and participating households, permission was sought from the household head or another adult in the household if the household head was absent. Households where all members refused to participate, or where all members were absent during the survey period, were excluded. All survey questions are described in the Codebook of the Underlying data 26.
Variables
The exposure variables were the rural/urban setting and helminth infection status. The outcomes were insulin resistance (measured using the homeostatic model assessment of insulin resistance (HOMA-IR; HOMA-IR = fasting serum insulin x fasting glucose / 22.5), fasting blood glucose, total cholesterol, triglyceride levels, High Density Lipoprotein (HDL) - cholesterol and low density lipoprotein (LDL) – cholesterol, blood pressure, body mass index (BMI), waist and hip circumference. Following a reviewer’s suggestion, we also included mean pancreatic beta cell function (HOMA-B) as an outcome. HOMA-B was calculated using the formula, HOMA-B=(20 × fasting insulin (μIU/ml)/fasting glucose (mmol/ml) − 3.5)].
Data sources/ study procedures
The tools and procedures of both surveys were aligned to allow comparison of the metabolic outcomes data between urban and rural settings. A questionnaire was administered to consenting household members. With this questionnaire, data were collected on household and individual sociodemographic characteristics as well as information on lifestyle, exercise or vigorous physical activity, diet, history of diabetes and hypertension.
A physical examination was performed and information obtained on blood pressure, weight, height, waist and hip circumference. With the participant seated, rested and comfortable, blood pressure was measured using a digital sphygmomanometer (OMRON Model M2[hem-7121-E], Omron Health Care, Kyoto, Japan). Three blood pressure measurements were taken five minutes apart, with the average of the last two measurements used for the analysis. A portable, flat digital weighing scale (SECA model 875 7021094, Hamburg, Germany) was used to take two measurements of body weight for each participant and the average of the two readings computed and used in the analysis. Height was measured using a stadiometer (SECA model 213 1721009, Hamburg, Germany) and recorded to the nearest millimetre. Two readings were obtained and the mean was used in the analysis. Quality control checks, using standard calibration rods for the stadiometers and standard weights for the weighing scales, were performed at the beginning of each working day. The sphygmomanometers were calibrated by the Uganda Bureau of Standards.
After an overnight fast, participants provided venous blood samples. The tests carried out on these samples included fasting blood glucose, insulin, fasting lipid profile and haemoparasitology. Fasting blood glucose, insulin and fasting lipid profile were tested using the COBAS cobas 6000 analyser ( cobas c 501 module, Roche Diagnostics, Rotkreuz, Switzerland). Mansonella perstans was tested using the modified Knott’s method 27.
Each participant was requested to provide one stool sample. Duplicate slides were made from each sample and the slides independently examined using the Kato Katz technique 28 by experienced technicians. Additionally, real-time stool polymerase chain reaction (PCR) was used to detect Schistosoma mansoni, Necator americanus and Strongyloides stercoralis 29, 30.
Diabetes and impaired fasting glucose were defined, according to the WHO classification, as fasting plasma glucose of ≥7.0 mmol/L and 6.1–6.9 mmol/L, respectively 31, 32. Hypertension was defined as diastolic blood pressure of ≥90 mmHg or systolic blood pressure of ≥140 mmHg in participants ≥18 years of age 33. Participants <18 years old were categorised to be hypertensive if their systolic or diastolic blood pressures were above the 95 th percentile using the Centers for Disease Control blood pressure charts for children and adolescents 34.
Sample size
In the rural setting, we aimed to recruit 1950 participants (sampling 70 households without replacement was expected to yield 75 participants aged ≥10 years from each of the 26 villages). This number was primarily calculated for the LaVIISWA trial analysis and was estimated to give 80% power to detect a difference in mean HOMA-IR of 0.05 between the trial arms assuming an intra-cluster correlation coefficient of 0.03 and a standard deviation on the log scale of 0.2. In the urban survey, we targeted a sample size of 960 individuals aged ten and over, and estimated that this would allow us to detect an absolute difference of 0.03 in mean HOMA-IR between urban and rural settings, assuming a standard deviation on the log scale of 0.2, and a design effect of 1.5. Assuming a 13% failure rate in household response and an average of around 2.3 individuals aged ≥10 years per household 480 households were targeted.
Statistical methods
The statistical analyses were performed using Stata version 13.0 (College Station, Texas, USA). We tabulated the characteristics of households and individuals in the urban setting alongside those of the rural setting in order to see how these differed between the two settings. We compared the outcomes between the rural setting and the urban setting. We summarised the mean for each outcome in the two settings and then assessed for differences by fitting regression models for each outcome that included a random effect to allow for the clustering (by village for the rural setting, by sub-ward for the urban setting) and a binary covariate that denoted whether the individual is in the urban or rural setting. Crude and adjusted mean differences and 95% confidence intervals are presented. All the outcomes were initially adjusted for age and sex and further adjusted for occupation, exercise, alcohol intake and smoking. HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic blood pressure were additionally adjusted for BMI. We did not perform any adjustments for multiple testing. In all analyses, data from the rural setting comprised all participants regardless of whether they had received intensive or standard anthelminthic treatment, i.e. both arms of the LaVIISWA trial were included. This was done because there were no strong differences in the outcomes between the trial arms 22.
To investigate whether helminths influence the differences observed in the metabolic outcomes, each helminth variable was added separately to the model and any change in the mean difference, confidence interval and p-values were assessed. Helminths were considered to have an influence on the urban-rural differences if addition of the variable resulted in a substantial change in the mean difference.
Ethical approval and consent
Ethical approval was granted by the Uganda Virus Research Institute Research Ethics committee (reference number GC/127/17/01/573), the Uganda National Council for Science and Technology (reference number HS 2185) and the London School of Hygiene and Tropical Medicine (reference number 9917). Permission to conduct the surveys was granted by the local leadership of Mukono district (for the rural survey) and Entebbe municipality (for the urban survey). All participating adults and emancipated minors provided written informed consent. Participants aged 10 to 17 years provided assent and their parents/guardians provided written informed consent.
Results
Participants
The survey flow is shown in Figure 2. In the rural setting, 2167 individuals aged 10 years and above from 1271 households were eligible for participation. Of these, 1898/2167 (87.6%) consented and provided data. In the urban setting, 1124 individuals from 416 households were eligible and 930/1124 (82.7%) consented and provided data. One sub-ward was a military facility and could not be surveyed because the study team was not granted access. In both surveys, the main reasons for non-participation were absenteeism (180/2167;8.3% in the rural setting and 165/1124;14.7% in the urban setting) and refusal (80/2167;3.7% in the rural setting and 18/1124;1.6% in the urban setting). Individual-level demographic data and survey responses are available as Underlying data 26.
Figure 2. Study flow chart.
Descriptive data
The characteristics of the study participants are shown in Table 1. Male participants constituted approximately half (51%; 1010/1890) and 35% (322/920) of the participants in the rural and urban survey respectively. The mean age of the participants was 31.5 years in the rural setting and 29.7 years in the urban setting. In the rural survey, the main economic activity was fishing (739/1898;37.9%) while in the urban setting most participants were involved in service provision, were artisans or had shops and salons (211/917;23.9%). The rural population was more physically active with 49.3% (920/1868) reporting exercise or vigorous physical activity at least once a week compared to 16.6% (152/914) in the urban setting. More participants in the rural setting reported having ever smoked (343/1868;18.3% vs 38/914;4.2%) or taken alcohol (905/1868;47.5% vs 187/914;20.5%) compared to those in the urban setting.
Table 1. Characteristics of participants in the rural and urban settings.
| Household-level characteristics | Rural setting
n/N (%) |
Urban
setting n/N (%) |
P
value * |
|---|---|---|---|
| Total number of households participating in
the survey |
1271 | 416 | |
| Household size (median, IQR) | 2 (1,3) | 4 (2,5) | |
| Individual-level characteristics | |||
| Sex, male | 1010/1898 (51.2) | 322/920 (35.0) | <0.001 |
| Age | |||
| Age in years (mean, SD) | 31.5 (11.0) | 29.7 (15.0) | 0.003 |
| Age in years, grouped | |||
| 10–19 | 215/1898 (11.8) | 261/920 (28.4) | <0.001 |
| 20–29 | 648/1898 (33.7) | 298/920 (32.4) | |
| 30–39 | 594/1898 (30.7) | 164/920 (17.8) | |
| 40+ | 441/1898 (23.7) | 197/920 (21.4) | |
| Occupation | |||
| Child/student | 121/1898 (7.2) | 253/917 (27.6) | <0.001 |
| Housewife | 199/1898 (9.7) | 166/917 (18.0) | |
| Fishing or lake related | 739/1898 (37.9) | 17/917 (1.9) | |
| Shops, salons, artisans, service
providers |
214/1898 (13.0) | 211/917 (23.9) | |
| Bars, restaurants, food providers,
entertainment |
160/1898 (8.4) | 48/917 (5.2) | |
| Agriculture, lumbering, charcoal | 396/1898 (19.2) | 35/917 (3.8) | |
| Professional | 33/1898 (2.3) | 37/917 (4.0) | |
| Unemployed | 36/1898 (2.4) | 128/917 (14.0) | |
| Other (not specified) | 0 | 22/917 (2.4) | |
| Residence | |||
| Always lived in the study area | 164/1898 (8.6) | 454/919 (49.4) | <0.001 |
| Place of birth | |||
| Village | 1716/1898 (90.2) | 318/918 (34.6) | <0.001 |
| Town or city | 182/1898 (9.8) | 600/918 (65.4) | |
| First five years | |||
| Village | 1700/1885 (89.8) | 339/918 (36.9) | <0.001 |
| Town or city | 185/1885 (10.2) | 579/918 (63.1) | |
| Age of participant when he/she moved to this
village (mean, SD) |
23.0 (11.2) | 22.8 (11.3) | 0.388 |
| Parental tribe | |||
| Maternal tribe region of origin | |||
| Central | 678/1898 (36.7) | 400/918 (43.5) | 0.097 |
| Western | 294/1898 (15.3) | 190/918 (20.7) | |
| Eastern | 405/1898 (21.0) | 131/918 (14.3) | |
| Northern | 202/1898 (10.1) | 110/918 (12.0) | |
| Non-Ugandan | 311/1898 (16.6) | 81/918 (8.8) | |
| Do not know | 8/1898 (0.4) | 6/918 (0.7) | |
| Paternal tribe region of origin | |||
| Central | 751/1898 (39.1) | 404/918 (44.0) | 0.202 |
| Western | 328/1898 (17.6) | 172/918 (18.7) | |
| Eastern | 385/1898 (20.6) | 152/918 (16.6) | |
| Northern | 201/1898 (10.3) | 115/918 (12.5) | |
| Non-Ugandan | 230/1898 (12.2) | 71/918 (7.7) | |
| Do not know | 3/1898 (0.2) | 4/918 (0.4) | |
| Treatment for worms | |||
| Ever treated for worms | 1661/1896 (86.9) | 646/888 (72.8) | <0.001 |
| Treated with albendazole in the last 12 months | 1301/1597 (82.1) | 480/641 (74.9) | 0.666 |
| Treated with praziquantel in the last 12
months |
1113/1604 (67.2) | 19/639 (3.0) | <0.001 |
| Lake contact | |||
| Frequency of lake contact | |||
| Every day | 1309/1857 (67.5) | 30/916 (3.3) | <0.001 |
| Almost every day | 297/1857 (16.3) | 36/916 (3.9) | |
| Once a week | 192/1857 (11.9) | 44/916 (4.8) | |
| Once a month | 52/1857 (3.8) | 120/916 (13.1) | |
| Less than once a month | 7/1857 (0.6) | 686/916 (74.9) | |
| Diabetes | |||
| History of diabetes | |||
| Yes | 7/1868 (0.5) | 26/914 (2.8) | <0.001 |
| No | 1841/1868 (98.7) | 808/914 (88.4) | |
| Do not know | 20/1868 (0.9) | 80/914 (8.8) | |
| Hypertension | |||
| History of hypertension | |||
| Yes | 44/1868 (3.0) | 77/914 (8.4) | <0.001 |
| No | 1815/1868 (96.5) | 811/914 (88.7) | |
| Do not know | 9/1868 (0.5) | 26/914 (2.8) | |
| Exercise | |||
| How often do you exercise / participate in
vigorous physical activity |
|||
| Every day | 28/1868 (1.4) | 11/914 (1.2) | <0.001 |
| Almost every day | 396/1868 (21.1) | 53/914 (5.8) | |
| Once a week | 496/1868 (27.3) | 88/914 (9.6) | |
| Once a month | 372/1868 (18.7) | 90/914 (9.9) | |
| Less than once a month | 576/1868 (31.5) | 672/914 (73.5) | |
| History of smoking and alcohol intake | |||
| Ever smoked (either pipe or cigarette) | 343/1868 (18.3) | 38/914 (4.2) | <0.001 |
| Ever taken alcohol | 905/1868 (47.5) | 187/914 (20.5) | <0.001 |
| Helminth infections | |||
| Schistosoma mansoni, stool Kato Katz | 440/1505 (31.7) | 76/770 (9.9) | <0.001 |
| Schistosoma mansoni intensity, stool Kato Katz | |||
| Uninfected | 1065/1505 (68.3) | 694/770 (90.1) | <0.001 |
| Light | 230/1505 (16.6) | 36/770 (4.7) | |
| Moderate | 121/1505 (8.6) | 27/770 (3.5) | |
| Heavy | 89/1505 (6.5) | 13/770 (1.7) | |
| Schistosoma mansoni, stool PCR | 694/1487 (47.6) | 171/771 (22.2) | <0.001 |
| Hookworm, stool Kato Katz | 39/1505 (2.4) | 25/769 (3.3) | 0.308 |
| Hookworm, stool PCR | 55/1364 (3.7) | 43/771 (5.6) | 0.145 |
| Trichuris trichiura, stool Kato Katz | 122/1505 (6.9) | 17/770 (2.2) | 0.002 |
| Ascaris lumbricoides, stool Kato Katz | 3/1505 (0.2) | 0 | - |
| Mansonella perstans, modified Knott’s | 20/1677 (1.1) | 3/918 (0.3) | 0.143 |
| Strongyloides stercoralis, stool PCR | 101/1486 (6.1) | 25/771 (3.2) | 0.026 |
Percentages adjusted for survey design; *P values obtained from survey design-based regression.
The rural participants had more exposure to the lake with 67.5% (1309/1857) reporting daily lake contact compared to only 3.3% (30/916) in the urban setting. Regarding anthelminthic treatment, 86.9% (1661/1896) of participants in the rural setting reported having ever received treatment for worms compared to 72.8% (646/888) of urban participants. Of these, 67.2% (1113/1604) in the rural setting reported having been treated with praziquantel in the last 12 months compared to 3.0% (19/639) in the urban setting. Helminth prevalence was higher in the rural setting with a significantly higher prevalence of S. mansoni (stool Kato Katz, 31.7% vs 9.9%, p<0.001; stool PCR 47.6% vs 22.2%, p<0.001), Trichuris trichiura (stool Kato Katz, 6.9% vs 2.2%, p=0.002) and Strongyloides stercoralis (stool PCR, 6.1% vs 3.2%, p=0.026). In both settings, most of the S. mansoni infections were of light intensity.
Rural-urban differences in metabolic outcomes
The metabolic outcomes measured in both settings are shown in Table 2. Mean fasting glucose was higher in the rural setting than in the urban setting (4.81 vs 4.71 mmol/L; adjusted mean difference -0.26 [95% confidence interval -0.40, -0.11] p=0.001). In unadjusted analyses and following adjustment for age and sex, no differences were seen in HOMA-IR. However, after further adjustment for BMI, exercise, alcohol intake and smoking, there was a negative mean difference suggesting higher HOMA-IR in the rural setting. The mean difference was most altered by adjusting for BMI. Following inclusion of HOMA-B as an additional outcome at the suggestion of a review, we found that individuals in the rural setting had lower (worse) pancreatic beta cell function than individuals in the urban setting even after adjusting for age, sex, exercise, alcohol intake, smoking and BMI (141.34 vs 201.72; 40.36 [8.00, 72.72] p=0.02].
Table 2. Comparison of metabolic outcomes in the urban and rural settings.
| Outcome | Mean | Crude
mean difference (95% CI) |
P-value |
*Adjusted
mean difference (95% CI) |
*P-value |
**Adjusted
mean difference (95% CI) |
**P-value | |
|---|---|---|---|---|---|---|---|---|
| Rural | Urban | |||||||
| HOMA – IR | GM 1.86 | GM 2.40 | 0.08 (-0.07, 0.23) | 0.28 | -0.02 (-0.16, 0.13) | 0.79 | -0.18 (-0.32, -0.05) | 0.01 |
| Fasting glucose (mmol/L) | 4.81 | 4.71 | -0.10 (-0.20, 0.00) | 0.05 | -0.10 (-0.20, 0.01) | 0.06 | -0.26 (-0.40, -0.11) | 0.001 |
| Fasting insulin ( µU/ml) | GM 66.99 | GM 87.26 | 0.12 (-0.03, 0.26) | 0.11 | 0.01 (-0.12, 0.15) | 0.84 | -0.12 (-0.25, 0.01) | 0.06 |
| Triglycerides (mmol/L) | 1.10 | 1.16 | 0.07 (-0.05, 0.19) | 0.27 | 0.10 (-0.03, 0.22) | 0.12 | 0.10 (-0.03, 0.23) | 0.12 |
| Total cholesterol (mmol/L) | 4.48 | 4.58 | 0.10 (-0.21, 0.40) | 0.53 | 0.12 (-0.18, 0.41) | 0.42 | 0.15 (-0.14, 0.44) | 0.31 |
| LDL – Cholesterol (mmol/L) | 2.66 | 2.85 | 0.19 (-0.22, 0.60) | 0.35 | 0.19 (-0.22, 0.60) | 0.35 | 0.21 (-0.27, 0.70) | 0.37 |
| HDL – Cholesterol (mmol/L) | 1.42 | 1.31 | -0.11 (-0.35, 0.12) | 0.34 | -0.10 (-0.33, 0.13) | 0.38 | -0.07 (-0.37, 0.23) | 0.63 |
| Systolic blood pressure
(mmHg) |
114.21 | 117.28 | 3.07 (1.60, 4.53) | <0.001 | 5.66 (4.35, 6.96) | <0.001 | 5.45 (3.75, 7.15) | <0.001 |
| Diastolic blood pressure
(mmHg) |
75.81 | 76.49 | 0.67 (-0.45, 1.80) | 0.24 | 2.23 (1.26, 3.21) | <0.001 | 1.93 (0.57, 3.29) | 0.006 |
| Body mass index (kg/m2) | 23.40 | 23.83 | 0.43 (-0.12, 0.97) | 0.12 | 0.81 (0.40, 1.23) | <0.001 | 1.07 (0.59, 1.54) | <0.001 |
| Waist circumference (cm) | 80.44 | 78.95 | -1.49 (-3.42, 0.43) | 0.13 | 0.24 (-1.35, 1.82) | 0.77 | 0.24 (-1.71, 2.19) | 0.81 |
| Waist-hip Ratio | GM 0.68 | GM 0.71 | 0.02 (-0.01, 0.05) | 0.26 | 0.02 (-0.01, 0.05) | 0.11 | 0.03 (-0.01, 0.06) | 0.17 |
HOMA-IR, Homeostatic model assessment of insulin resistance; GM, geometric means; P values obtained from survey design-based linear regression; *Adjusted for age and sex; **Adjusted for age, sex, occupation, exercise, alcohol intake and smoking; HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic BP were additionally adjusted for BMI.
Participants in the rural setting had significantly lower mean blood pressure than those in the urban setting even after adjustment for sex, age, exercise, alcohol, smoking and BMI (systolic blood pressure, 114.21 vs 117.28 mmHg 5.45 [3.75, 7.15] p<0.001; diastolic blood pressure 75.81 vs 76.49 mmHg, 1.93 [0.57, 3.29] p=0.006). These differences in blood pressure were more marked in the older age groups ( Figure 3).
Figure 3. Variation of mean systolic and diastolic blood pressure with age in the rural and urban settings.
The shaded areas represent 95% confidence intervals (allowing for clustering) around the mean systolic and diastolic blood pressure measurements for each age group.
Participants in the rural setting had lower mean BMI than those in the urban setting. No differences were observed for waist circumference, waist-hip ratio, triglycerides, total cholesterol, LDL-cholesterol or HDL-cholesterol.
Despite having, on average, higher fasting glucose in the rural setting, there was no difference in the prevalence of diabetes between the rural and urban settings after adjusting for multiple potential confounders. However, the rural setting had a lower prevalence of hypertension (9.1% vs 13.4%, p=0.01) and obesity (7.7% vs 14.0%, p<0.001), than the urban setting ( Table 3 and Table 4).
Table 3. Comparison of metabolic outcomes by disease categories.
| Outcome | n/N (%) | Crude
odds ratios (95% CI) |
P-value |
*Adjusted
odds ratios (95% CI) |
*P-value |
**Adjusted
odds ratios (95% CI) |
**P-value | |
|---|---|---|---|---|---|---|---|---|
| Rural | Urban | |||||||
| Diabetes (FBG ≥ 7 mmol/l) | 16/1681 (1.0) | 22/902 (2.4) | 2.41 (1.32, 4.40) | 0.01 | 2.45 (1.31, 4.58) | 0.01 | 1.84 (0.79, 4.27) | 0.15 |
| Impaired fasting glucose (FBG 6.1 –
6.9 mmol/l) |
35/1681 (1.9) | 14/902 (1.6) | 0.84 (0.39, 1.81) | 0.66 | 0.92 (0.42, 2.06) | 0.84 | 1.05 (0.42, 2.63) | 0.92 |
| Hypertension *** | 156/1813 (9.1) | 123/916 (13.4) | 1.60 (1.14, 2.25) | 0.01 | 2.36 (1.67, 3.34) | <0.001 | 1.81 (1.15, 2.83) | 0.01 |
| Prehypertension | 574/1813 (30.7) | 285/916 (31.1) | 1.10 (0.89, 1.36) | 0.36 | 1.58 (1.26, 1.98) | <0.001 | 1.64 (1.16, 2.33) | 0.01 |
| Obese (BMI ≥ 30) | 128/1815 (7.7) | 130/ 926 (14.0) | 2.34 (1.70, 3.22) | <0.001 | 2.28 (1.60, 3.23) | <0.001 | 2.36 (1.55, 3.60) | <0.001 |
| Overweight (BMI 25.0 – 29.9) | 349/1815 (19.9) | 188/ 926 (20.3) | 1.30 (0.99, 1.70) | 0.06 | 1.33 (1.00, 1.77) | 0.05 | 1.45 (0.96, 2.17) | 0.08 |
| Underweight (BMI <18.5) | 119/1815 (7.0) | 132/ 926 (14.3) | 2.61 (1.72, 3.96) | <0.001 | 1.54 (1.04, 2.29) | 0.03 | 1.00 (0.56, 1.78) | 0.99 |
| Central (abdominal) obesity
(WC≥94cm males, WC ≥80cm females) |
511/1813 (29.7) | 321/925 (34.7) | 1.26 (0.94, 1.68) | 0.12 | 1.15 (0.83, 1.59) | 0.38 | 1.32 (0.86, 2.04) | 0.20 |
| Central (abdominal) obesity (WHR>0.9
males, WHR>0.85 females) |
505/1813 (27.8) | 227/925 (24.5) | 0.84 (0.63, 1.12) | 0.24 | 0.75 (0.55, 1.02) | 0.06 | 0.74 (0.53, 1.03) | 0.08 |
| Metabolic Syndrome **** | 109/1675 (6.4) | 77/908 (8.5) | 1.37 (0.88, 2.13) | 0.16 | 1.30 (0.83, 2.04) | 0.24 | 0.74 (0.53, 1.03) | 0.08 |
FBG, Fasting Blood Glucose; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; BMI, Body Mass Index; WC, Waist Circumference; WHR, Waist Hip Ratio; *Adjusted for age and sex; P values obtained from survey design-based logistic regression; **Adjusted for age, sex, occupation, exercise, alcohol intake and smoking; diabetes, impaired fasting glucose, hypertension and prehypertension were additionally adjusted for BMI; *** SBP ≥ 140mmHg or DBP ≥ 90mmHg for adults; Blood pressure ≥90 th percentile for participants aged 10–17 years; ****Any three of: Central obesity [WC≥94cm males WC ≥80cm Females], FBG>5.55, [SBP≥130 or DBP≥85], Elevated Triglycerides [≥1.7 mmol/L], Reduced HDL – Cholesterol [<1 mmol/L Males, <1.3 mmol/L females.
Table 4. Comparison of metabolic outcomes by disease categories in adult participants (aged ≥18 years).
| Outcome | n/N (%) | Crude
odds ratios (95% CI) |
P-value |
*Adjusted
odds ratios (95% CI) |
*P-value | |
|---|---|---|---|---|---|---|
| Rural | Urban | |||||
| Diabetes (FBG ≥ 7 mmol/l) | 16/1551 (1.1) | 21/716 (2.9) | 2.66 (1.45, 4.89) | 0.002 | 2.34 (1.24, 4.40) | 0.01 |
| Impaired fasting glucose (FBG 6.1 – 6.9 mmol/l) | 33/1551 (1.9) | 12/716 (1.7) | 0.89 (0.40, 2.01) | 0.78 | 0.94 (0.41, 2.13) | 0.87 |
| Hypertension ** | 152/1678 (9.5) | 116/727 (16.0) | 2.01 (1.46, 2.77) | <0.001 | 2.62 (1.86, 3.69) | <0.001 |
| Obese (BMI ≥ 30) | 127/1679 (8.3) | 128/732 (17.5) | 2.64 (1.92, 3.64) | <0.001 | 2.31 (1.64, 3.26) | <0.001 |
| Overweight (BMI 25.0 – 29.9) | 346/1679 (21.4) | 177/732 (24.2) | 1.41 (1.08, 1.84) | 0.01 | 1.32 (1.00, 1.74) | 0.05 |
| Underweight (BMI <18.5) | 51/1679 (3.2) | 33/732 (4.5) | 1.73 (0.96, 3.14) | 0.07 | 1.90 (1.08, 3.36) | 0.03 |
| Central (abdominal) obesity (WC≥94cm males,
WC ≥80cm females) |
505/1677 (31.9) | 310/731 (42.4) | 1.57 (1.17, 2.13) | 0.004 | 1.18 (0.85, 1.63) | 0.32 |
| Central (abdominal) obesity (WHR>0.9 males,
WHR>0.85 females) |
471/1677 (28.2) | 202/731 (27.6) | 0.97 (0.73, 1.29) | 0.85 | 0.80 (0.59, 1.08) | 0.14 |
| ***Metabolic Syndrome | 108/1547 (6.9) | 76/719 (10.6) | 1.59 (1.04, 2.44) | 0.03 | 1.30 (0.84, 2.02) | 0.24 |
FBG, Fasting Blood Glucose; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; BMI, Body Mass Index; WC, Waist Circumference; WHR, Waist Hip Ratio; *Adjusted for age and sex; P values obtained from survey design-based logistic regression; ** SBP ≥ 140mmHg or DBP ≥ 90mmHg for adults; Blood pressure ≥90 th percentile for participants aged 10–17 years; ***Any three of: Central obesity [WC≥94cm males WC ≥80cm Females], FBG>5.55, [SBP≥130 or DBP≥85], Elevated Triglycerides [≥1.7 mmol/L], Reduced HDL – Cholesterol [<1 mmol/L Males, <1.3 mmol/L females.
Helminth infection and intensity did not explain the rural urban differences observed for the metabolic parameters: very little change was seen in the mean differences after further adjustment for helminth infection status or helminth infection intensity ( Table 5).
Table 5. Effect of adjusting for helminths on differences in metabolic outcomes.
| Outcome | Mean | Crude
mean difference (95% CI) |
P-value |
*Adjusted
mean difference (95% CI) |
*P-
value |
**Adjusted
mean difference (95% CI) |
**P-
value |
|
|---|---|---|---|---|---|---|---|---|
| Rural | Urban | |||||||
| HOMA – IR | GM 1.86 | GM 2.40 | 0.08 (-0.07, 0.23) | 0.28 | -0.02 (-0.16, 0.13) | 0.79 | -0.13 (-0.25, -0.01) | 0.04 |
| With each helminth included in
the model |
||||||||
| S. mansoni KK (n=2092) | 0.07 (-0.08, 0.21) | 0.38 | -0.01 (-0.15, 0.14) | 0.95 | -0.12 (-0.25, 0.02) | 0.09 | ||
| S. mansoni PCR (n=2077) | 0.05 (-0.10, 0.19) | 0.54 | -0.03 (-0.17, 0.11) | 0.70 | -0.13 (-0.25, 0 .00) | 0.06 | ||
| S. mansoni intensity KK (n=2092) | 0.07 (-0.08, 0.21) | 0.37 | 0.00 (-0.15, 0.14) | 0.97 | -0.11 (-0.24, 0.02) | 0.09 | ||
| T. trichiura KK (n=2092) | 0.08 (-0.07, 0.22) | 0.32 | -0.02 (-0.16, 0.13) | 0.82 | -0.12 (-0.25, 0.01) | 0.07 | ||
| Hookworm PCR (n=1962) | 0.07 (-0.08, 0.22) | 0.33 | -0.02 (-0.16, 0.13) | 0.82 | -0.12 (-0.25, 0.02) | 0.08 | ||
| S. stercoralis PCR (n=2076) | 0.06 (-0.09, 0.21) | 0.41 | -0.02 (-0.17, 0.13) | 0.78 | -0.12 (-0.26, 0.01) | 0.06 | ||
| Any worm (n=2028) | 0.05 (-0.10, 0.19) | 0.54 | -0.03 (-0.17, 0.11) | 0.66 | -0.13 (-0.25, 0.00) | 0.05 | ||
| Fasting glucose (mmol/L) | 4.81 | 4.71 | -0.10 (-0.20, 0.00) | 0.05 | -0.10 (-0.20, 0.01) | 0.06 | -0.13 (-0.24, -0.01) | 0.04 |
| With each helminth included in the
model |
||||||||
| S. mansoni KK (n= 2109) | -0.10 (-0.22, 0.02) | 0.09 | -0.07 (-0.19, 0.04) | 0.21 | -0.11 (-0.23, 0.02) | 0.08 | ||
| S. mansoni PCR (n=2094) | -0.12 (-0.24, 0.00) | 0.05 | -0.10 (-0.21, 0.02) | 0.11 | -0.13 (-0.25, 0.00) | 0.04 | ||
| S. mansoni intensity KK (n=2109) | -0.10 (-0.22, 0.02) | 0.10 | -0.07 (-0.19, 0.04) | 0.22 | -0.11 (-0.23, 0.02) | 0.09 | ||
| T. trichiura KK (n=2109) | -0.08 (-0.19, 0.03) | 0.14 | -0.08 (-0.19, 0.03) | 0.17 | -0.11 (-0.23, 0.01) | 0.07 | ||
| Hookworm PCR (n=1979) | -0.08 (-0.19, 0.03) | 0.15 | -0.07 (-0.18, 0.04) | 0.20 | -0.11 (-0.23, 0.02) | 0.09 | ||
| S. stercoralis PCR (n=2093) | -0.08 (-0.19, 0.04) | 0.194 | -0.07 (-0.19, 0.04) | 0.20 | -0.11 (-0.23, 0.02) | 0.09 | ||
| Any worm (n=2045) | -0.12 (-0.25, 0.01) | 0.06 | -0.10 (-0.22, 0.03) | 0.12 | -0.13 (-0.26, 0.00) | 0.05 | ||
| Systolic blood pressure (mmHg) | 114.21 | 117.28 | 3.07 (1.60, 4.53) | <0.001 | 5.66 (4.35, 6.96) | <0.001 | 4.64 (3.23, 6.06) | <0.001 |
| With each helminth included in the
model |
||||||||
| S. mansoni KK (n=2187) | 3.47 (1.93, 5.01) | <0.001 | 5.94 (4.51, 7.38) | <0.001 | 4.66 (2.93, 6.39) | <0.001 | ||
| S. mansoni PCR (n=2172) | 3.45 (1.99, 4.92) | <0.001 | 5.82 (4.58, 7.06) | <0.001 | 4.67 (3.16, 6.19) | <0.001 | ||
| S. mansoni intensity KK (n=2187) | 3.47 (1.95, 5.00) | <0.001 | 5.94 (4.53, 7.36) | <0.001 | 4.65 (2.96, 6.34) | <0.001 | ||
| T. trichiura KK (n=2187) | 3.10 (1.75, 4.45) | <0.001 | 5.65 (4.37, 6.92) | <0.001 | 4.45 (2.89, 6.00) | <0.001 | ||
| Hookworm PCR (n=2054) | 3.42 (1.98, 4.86) | <0.001 | 5.88 (4.58, 7.18) | <0.001 | 4.64 (3.11, 6.18) | <0.001 | ||
| S. stercoralis PCR (n=2171) | 3.49 (2.10, 4.89) | <0.001 | 5.83 (4.55, 7.11) | <0.001 | 4.65 (3.13, 6.18) | <0.001 | ||
| Any worm (n=2122) | 3.30 (1.90, 4.70) | <0.001 | 5.71 (4.49, 6.92) | <0.001 | 4.53 (3.04, 6.03) | <0.001 | ||
| Diastolic blood pressure (mmHg) | 75.81 | 76.49 | 0.67 (-0.45, 1.80) | 0.24 | 2.23 (1.26, 3.21) | <0.001 | 1.89 (0.81, 2.97) | 0.001 |
| With each helminth included in
the model |
||||||||
| S. mansoni KK (n=2187) | 0.34 (-0.84, 1.51) | 0.567 | 2.17 (1.15, 3.18) | <0.001 | 1.71 (0.59, 2.84) | 0.004 | ||
| S. mansoni PCR (n=2172) | 0.38 (-0.72, 1.48) | 0.492 | 2.10 (1.15, 3.05) | <0.001 | 1.73 (0.65, 2.80) | 0.002 | ||
| S. mansoni intensity KK (n=2187) | 0.32 (-0.88, 1.51) | 0.596 | 2.15 (1.11, 3.18) | <0.001 | 1.67 (0.54, 2.80) | 0.005 | ||
| T. trichiura KK (n=2187) | 0.35 (-0.84, 1.54) | 0.554 | 1.97 (0.97, 2.97) | <0.001 | 1.55 (0.46, 2.63) | 0.006 | ||
| Hookworm PCR (n=2054) | 0.51 (-0.66, 1.69) | 0.385 | 2.08 (1.07, 3.09) | <0.001 | 1.70 (0.59, 2.80) | 0.003 | ||
| S. stercoralis PCR (n=2171) | 0.57 (-0.60, 1.74) | 0.330 | 2.08 (1.08, 3.08) | <0.001 | 1.71 (0.60, 2.82) | 0.003 | ||
| Any worm (n=2122) | 0.29 (-0.79, 1.36) | 0.592 | 2.00 (1.06, 2.94) | <0.001 | 1.62 (0.59, 2.65) | 0.003 | ||
| Body mass index (kg/m2) | 23.40 | 23.83 | 0.43 (-0.12, 0.97) | 0.12 | 0.81 (0.40, 1.23) | <0.001 | 0.60 (0.10, 1.10) | 0.020 |
| With each helminth included in the
model |
||||||||
| S. mansoni KK (n=2158) | 0.19 (-0.38, 0.76) | 0.499 | 0.88 (0.43, 1.34) | <0.001 | 0.71 (0.11, 1.31) | 0.021 | ||
| S. mansoni PCR (n=2143) | 0.18 (-0.40, 0.76) | 0.535 | 0.80 (0.31, 1.29) | 0.002 | 0.64 (0.01, 1.27) | 0.046 | ||
| S. mansoni intensity KK (n=2158) | 0.20 (-0.38, 0.77) | 0.496 | 0.89 (0.43, 1.35) | <0.001 | 0.72 (0.11, 1.32) | 0.022 | ||
| T. trichiura KK (n=2158) | 0.39 (-0.17, 0.95) | 0.166 | 0.81 (0.37, 1.25) | 0.001 | 0.64 (0.06, 1.22) | 0.032 | ||
| Hookworm PCR (n=2027) | 0.48 (-0.09, 1.05) | 0.094 | 0.87 (0.41, 1.34) | <0.001 | 0.73 (0.14, 1.33) | 0.017 | ||
| S. stercoralis PCR (n=2142) | 0.43 (-0.14, 1.00) | 0.136 | 0.83 (0.37, 1.29) | 0.001 | 0.67 (0.09, 1.25) | 0.024 | ||
| Any worm (n=2094) | 0.23 (-0.35, 0.81) | 0.436 | 0.81 (0.34, 1.28) | 0.001 | 0.67 (0.06, 1.28) | 0.033 | ||
HOMA-IR, Homeostatic model assessment of insulin resistance; GM, geometric means; P values obtained from survey design-based linear regression; *Adjusted for age and sex: **Adjusted for age, sex, exercise, alcohol intake and smoking; HOMA-IR, fasting glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic and diastolic BP were additionally adjusted for BMI.
Discussion
In this paper, we have shown that individuals in a rural, high helminth transmission setting had higher mean HOMA-IR and fasting glucose, and lower pancreatic beta cell function than those in an urban low helminth transmission setting. They also had substantially lower blood pressure and BMI than their urban counterparts. This was not explained by differences in activity levels, age or sex or (for blood pressure) BMI and we did not find any impact of helminth infection on the observed rural-urban differences.
In our relatively young study population, the prevalence of diabetes was low in both settings. It was surprising to find a higher mean fasting glucose and insulin resistance and lower pancreatic beta cell function in the rural setting. Although a higher diabetes prevalence in a rural setting compared to the urban setting has been reported in a study among secondary school students in Cameroon, there was no significant difference in mean fasting glucose in that study 35. One possible explanation for our finding is occupational. The majority of our rural population is involved in fishing and fishing is mainly conducted at night. Night shift work has been associated with changes in the diurnal pattern of cortisol and consequently predicts increased concentrations of cortisol 36. Higher cortisol levels have been associated with raised plasma glucose and insulin resistance 37, 38. Shift work has been linked to an increased risk of diabetes 39, therefore, it is important to study how night time work in these rural fishing communities impacts metabolic health. Also, in view of their occupation, we cannot rule out the possibility that individuals in the rural setting were less adherent to the instructions on overnight fasting before the blood draw.
Another possible explanation is derived from the “thrifty phenotype hypothesis”, which proposes a link between poor fetal and early postnatal nutrition, and the development of T2D in adulthood 40. This hypothesis proposes that malnutrition in early life impedes development of the pancreas making the pancreas more susceptible to development of diabetes. Therefore, individuals who have spent their early life in rural areas (as most of the rural survey participants had done in this study), where undernutrition is more common, are more prone to glucose dysregulation.
The prevalence of hypertension was low in both settings. The rural environment was protective against hypertension, as suggested by the lower mean blood pressure and lower hypertension prevalence. This is in agreement with previous findings in Uganda and the region 41, 42. Taking into account the higher levels of physical activity and lower BMI among the rural participants in our study did not alter the result, neither did adjusting for smoking and alcohol intake. This implies that other protective factors associated with the rural environment, not measured in our study, such as lower sodium intake 43 and less pollution could be responsible for this. However, modernisation and change in household income may overturn the protective effects of the rural environment. For example, sodium intake in rural and urban Malawi is higher than the recommended amounts 44. Studies to investigate the trends in cardiometabolic risk factors in rural environments such as the fishing communities we studied are therefore important.
The rural-urban differences we observed in glucose metabolism, blood pressure and BMI could not be explained by the differences in current helminth prevalence. Given the existence of helminth infection in both settings, this is not surprising. The exposure to helminth infection in this particular urban setting (a peninsula, with easy access to the lake) was perhaps not low enough to eliminate helminth effects. Immunological changes induced by helminths can persist for long periods after clearance of the helminths 45. Lifestyle factors and other environmental exposures may be having a stronger influence on metabolic outcomes than helminths. However, investigating the role of helminths in the epidemiological transition still remains an important and interesting prospect worth pursuing. Indeed, our previous LaVIISWA trial and observational analyses suggested that schistosomiasis infection was associated with lower serum total cholesterol and LDL-cholesterol levels and that moderate to heavy S. mansoni infection was associated with lower triglycerides, LDL-cholesterol and diastolic blood pressure levels. Intensive anthelminthic treatment resulted in higher LDL-cholesterol levels, although helminths were still present in this intensively treated group, albeit with lower intensity than in residents of villages who received standard anthelminthic treatment 22. Further work in an area with lower helminth prevalence is required to investigate this hypothesis.
The strengths of our project include the large sample size and the uniqueness of the study settings in relation to helminth prevalence. However, we were limited by the cross-sectional nature of the study and therefore cannot make causal inferences from the results, and cannot investigate the longevity, in the context of lifestyle and epidemiological changes, of the observed differences. We performed multiple tests and did not formally correct for this, so cannot rule out chance findings, but all analyses were pre-planned and consistency between glucose and HOMA-IR and between diastolic and systolic blood pressure lend weight to the findings. Differences in socioeconomic status and diet were not assessed and it is possible that these might partially explain differences between rural and urban settings. Fishing communities are rather unique rural communities in relation to housing, lifestyle, diet and exposure to schistosomiasis, and may not be representative of all rural communities.
In conclusion, our findings raise important questions about blood glucose and the rural environment. Is the rural environment potentially detrimental to glucose metabolism? Will the source of the next epidemic of diabetes be the rural areas even when the rural environment still remains associated with a better blood pressure and anthropometric profile?
Data availability
Underlying data
LSHTM Data compass: Contrasting impact of rural, versus urban, living on glucose metabolism and blood pressure in Uganda. https://doi.org/10.17037/DATA.00001528 26.
This project contains the following underlying data:
Rural-urban_survey_data.csv (individual-level rural-urban survey data).
Rural-urban_survey_data_codebook.html (codebook for Rural-urban survey data; also lists all questions asked of study participants).
Data are available under the terms of the Creative Commons Attribution 3.0 International license (CC-BY 3.0).
Acknowledgements
We thank the community members of Koome sub-county and Entebbe Municipality, their local council leaders and village health team members for participating in these studies. We thank the leadership of Mukono and Wakiso Districts and particularly the district health officer – Mukono (Elly Tumushabe) and the councillor for Koome sub-county (Asuman Muwumuza), who are members of the LaVIISWA Trial Steering Committee (TSC), for their support. We also thank also the other members of the TSC: Heiner Grosskurth (chair), Edridah Tukahebwa, Narcis Kabatereine, Neil Pearce, Anatoli Kamali and Monica Kuteesa. We are grateful to Moffat Nyirenda, who is a member of Richard Sanya’s doctoral committee, for his guidance and support.
Funding Statement
These studies were funded by the Wellcome Trust, grant number 095778. Additional funding was provided by the Royal Society, grant number IC160132. RES is supported by a PhD fellowship awarded under the DELTAS Africa Initiative (Grant no. 107743); the DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant no. 107743) and the UK Government. The work was conducted at the MRC/UVRI and LSHTM Uganda Research Unit which is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[version 2; peer review: 2 approved]
References
- 1. GBD 2016 Causes of Death Collaborators: Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210. 10.1016/S0140-6736(17)32152-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. GBD 2016 DALYs and HALE Collaborators: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–344. 10.1016/S0140-6736(17)32130-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Noncommunicable diseases country profiles 2018. Geneva: World Health Organisation;2018. Reference Source [Google Scholar]
- 4. Patel RB, Burke TF: Urbanization--an emerging humanitarian disaster. N Engl J Med. 2009;361(8):741–3. 10.1056/NEJMp0810878 [DOI] [PubMed] [Google Scholar]
- 5. International Diabetes Federation: IDF Diabetes Atlas.8th ed.2017. Reference Source [Google Scholar]
- 6. Angkurawaranon C, Wisetborisut A, Rerkasem K, et al. : Early life urban exposure as a risk factor for developing obesity and impaired fasting glucose in later adulthood: results from two cohorts in Thailand. BMC Public Health. 2015;15:902. 10.1186/s12889-015-2220-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Yusuf S, Rangarajan S, Teo K, et al. : Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27. 10.1056/NEJMoa1311890 [DOI] [PubMed] [Google Scholar]
- 8. Kavishe B, Biraro S, Baisley K, et al. : High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015;13:126. 10.1186/s12916-015-0357-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Chiwanga FS, Njelekela MA, Diamond MB, et al. : Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda. Glob Health Action. 2016;9(1):31440. 10.3402/gha.v9.31440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Fezeu L, Kengne AP, Balkau B, et al. : Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health. 2010;64(4):360–5. 10.1136/jech.2008.086355 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Guwatudde D, Mutungi G, Wesonga R, et al. : The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey. PLoS One. 2015;10(9):e0138991. 10.1371/journal.pone.0138991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569(7755):260–4. 10.1038/s41586-019-1171-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Rook GAW: 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis. Clin Exp Immunol. 2010;160(1):70–9. 10.1111/j.1365-2249.2010.04133.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. 10.1038/nri2925 [DOI] [PubMed] [Google Scholar]
- 15. Gisterå A, Hansson GK: The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–80. 10.1038/nrneph.2017.51 [DOI] [PubMed] [Google Scholar]
- 16. Solak Y, Afsar B, Vaziri ND, et al. : Hypertension as an autoimmune and inflammatory disease. Hypertens Res. 2016;39(8):567–73. 10.1038/hr.2016.35 [DOI] [PubMed] [Google Scholar]
- 17. Tracey EF, McDermott RA, McDonald MI: Do worms protect against the metabolic syndrome? A systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;120:209–20. 10.1016/j.diabres.2016.08.014 [DOI] [PubMed] [Google Scholar]
- 18. Gurven MD, Trumble BC, Stieglitz J, et al. : Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health. 2016;2016(1):338–57. 10.1093/emph/eow028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Berbudi A, Ajendra J, Wardani AP, et al. : Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes. Diabetes Metab Res Rev. 2016;32(3):238–50. 10.1002/dmrr.2673 [DOI] [PubMed] [Google Scholar]
- 20. Nampijja M, Webb EL, Kaweesa J, et al. : The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial. Trials. 2015;16:187. 10.1186/s13063-015-0702-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Uganda Bureau of Statistics: The National Population and Housing Census 2014 – Sub-County Report.Kampala, Uganda.2016. Reference Source [Google Scholar]
- 22. Sanya RE, Webb EL, Zziwa C, et al. : The effect of helminth infections and their treatment on metabolic outcomes: results of a cluster-randomised trial. Clin Infect Dis. 2019; pii: ciz859. 10.1093/cid/ciz859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Nkurunungi G, Lubyayi L, Versteeg SA, et al. : Do helminth infections underpin urban-rural differences in risk factors for allergy-related outcomes? Clin Exp Allergy. 2019;49(5):663–76. 10.1111/cea.13335 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Nkurunungi G, van Diepen A, Nassuuna J, et al. : Microarray assessment of N-glycan-specific IgE and IgG profiles associated with Schistosoma mansoni infection in rural and urban Uganda. Sci Reps. 2019;9(1):3522. 10.1038/s41598-019-40009-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Uganda Bureau of Statistics: The National Population and Housing Census 2014 – Main Report.Kampala, Uganda: Uganda Bureau of Statistics.2016. Reference Source [Google Scholar]
- 26. Sanya R, Webb E: Contrasting impact of rural, versus urban, living on glucose metabolism and blood pressure in Uganda. [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom,2019. 10.17037/DATA.00001528 [DOI] [Google Scholar]
- 27. Melrose WD, Turner PF, Pisters P, et al. : An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg. 2000;94(2):176. 10.1016/s0035-9203(00)90266-9 [DOI] [PubMed] [Google Scholar]
- 28. Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397–400. [PubMed] [Google Scholar]
- 29. Verweij JJ, Brienen EA, Ziem J, et al. : Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am J Trop Med Hyg. 2007;77(4):685–90. 10.4269/ajtmh.2007.77.685 [DOI] [PubMed] [Google Scholar]
- 30. Verweij JJ, Canales M, Polman K, et al. : Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg. 2009;103(4):342–6. 10.1016/j.trstmh.2008.12.001 [DOI] [PubMed] [Google Scholar]
- 31. World Health Organisation: Global Report on Diabetes. Geneva, Switzerland.2016. Reference Source [Google Scholar]
- 32. World Health Organisation / International Diabetes Federation: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland.2006. Reference Source [Google Scholar]
- 33. Whelton PK, Carey RM, Aronow WS, et al. : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. 10.1016/j.jacc.2017.11.006 [DOI] [PubMed] [Google Scholar]
- 34. Falkner B, Daniels SR: Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Hypertension. 2004;44(4):387–8. 10.1161/01.HYP.0000143545.54637.af [DOI] [PubMed] [Google Scholar]
- 35. Kamdem F, Lemogoum D, Jingi AM, et al. : Prevalence and determinants of abnormal glucose metabolism in urban and rural secondary schools in Cameroon: A cross-sectional study in a sub-Saharan Africa setting. Prim Care Diabetes. 2019;13(4):370–375. 10.1016/j.pcd.2019.02.006 [DOI] [PubMed] [Google Scholar]
- 36. Li J, Bidlingmaier M, Petru R, et al. : Impact of shift work on the diurnal cortisol rhythm: a one-year longitudinal study in junior physicians. J Occup Med Toxicol. 2018;13:23. 10.1186/s12995-018-0204-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Phillips DI, Barker DJ, Fall CH, et al. : Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab. 1998;83(3):757–60. 10.1210/jcem.83.3.4634 [DOI] [PubMed] [Google Scholar]
- 38. Misra M, Bredella MA, Tsai P, et al. : Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab. 2008;295(2):E385–92. 10.1152/ajpendo.00052.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Gan Y, Yang C, Tong X, et al. : Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med. 2015;72(1):72–8. 10.1136/oemed-2014-102150 [DOI] [PubMed] [Google Scholar]
- 40. Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601. 10.1007/bf00400248 [DOI] [PubMed] [Google Scholar]
- 41. Price AJ, Crampin AC, Amberbir A, et al. : Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018;6(3):208–22. 10.1016/S2213-8587(17)30432-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, et al. : The burden of hypertension in sub-Saharan Africa: a four-country cross sectional study. BMC Public Health. 2015;15:1211. 10.1186/s12889-015-2546-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Mizehoun-Adissoda C, Houinato D, Houehanou C, et al. : Dietary sodium and potassium intakes: Data from urban and rural areas. Nutrition. 2017;33:35–41. 10.1016/j.nut.2016.08.007 [DOI] [PubMed] [Google Scholar]
- 44. Prynn JE, Banda L, Amberbir A, et al. : Dietary sodium intake in urban and rural Malawi, and directions for future interventions. Am J Clin Nutr. 2018;108(3):587–93. 10.1093/ajcn/nqy125 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Soonawala D, Geerts JW, de Mos M, et al. : The immune response to schistosome antigens in formerly infected travelers. Am J Trop Med Hyg. 2011;84(1):43–7. 10.4269/ajtmh.2011.10-0260 [DOI] [PMC free article] [PubMed] [Google Scholar]


